764779
Poly(ethylene glycol) methyl ether-block-poly(D,L lactide)
PEG average Mn 2,000, PDLLA average Mn 2,000
Synonym(s):
PEG-PDLLA
About This Item
Recommended Products
description
n=45, m=28 (typical)
typical PEG PDI<1.1; overall PDI<1.4 (THF, PEO)
form
pellets
mol wt
PDLLA average Mn 2,000
PEG average Mn 2,000
average Mn 4,000 (total)
degradation timeframe
2-4 weeks
transition temp
Tg 11 °C (PEG block)
Tm 244-248 °C
Tg 88 °C (PDLLA block)
PDI
≤1.4
storage temp.
2-8°C
General description
Application
Features and Benefits
- Good biocompatibility, low immunogenicity and good degradability.
- Properties can be easily modulated by changing the block copolymer segment sizes to suit a particular application.
Storage Class Code
11 - Combustible Solids
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Regulatory Listings
Regulatory Listings are mainly provided for chemical products. Only limited information can be provided here for non-chemical products. No entry means none of the components are listed. It is the user’s obligation to ensure the safe and legal use of the product.
JAN Code
764779-BULK:
764779-VAR:
764779-1G:
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Articles
Microparticle drug delivery systems have been extensively researched and applied to a wide variety of pharmaceutical and medical applications due to a number of advantages including injectability, local applicability to target tissues and sites, and controlled drug delivery over a given time period.
Local delivery of bioactive molecules using an implantable device can decrease the amount of drug dose required as well as non-target site toxicities compared to oral or systemic drug administration.
Aliphatic polyesters such as polylactide, poly(lactide-co-glycolide) and polycaprolactone, as well as their copolymers, represent a diverse family of synthetic biodegradable polymers that have been widely explored for medical uses and are commercially available.
The development of drugs that target specific locations within the human body remains one of the greatest challenges in biomedicine today.
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service